Furthermore, Th17 cells have the ability to maintain a stem cell-like phenotype by activating the HIF-1α/Notch/Bcl-2 axis, also indicating a correlation between Th17 activity and improved immune responses to tumour antigens [60]. This evidence concerns the gene BCL2 and neoplasm.